The diabetics have been reported to have decreased levels of Magnesium (4) and supplementation of Magnesium improves Insulin sensitivity and metabolic control in Type 2 diabetes (5). However, in present study chronic diabetic subjects with ESRD showed hypermagnesaemia which suggests the primitive role of magnesium in diabetes with ESRD.
Thus, the maintenance of normal levels of magnesium may be of great significance in the assessment of glycemia. Hence a routine monitoring of magnesium may be of significance to clinicians for better management of diabetes with ESRD. SIR-Magnesium is known to play an important role in carbohydrate metabolism and its imbalance has been implicated as a cause, consequence, or complications of diabetes mellitus. Magnesium serves as cofactor for about 300 cellular enzymes many of which are involved in energy and carbohydrate metabolism (1-4).
Disorders of mineral metabolism are among the less well understood clinical problems encountered by clinicians and magnesium heads that list. Hypermagnesemia has an impact on vital organs, which is usually seen in diabetic ESRD due to decreased excretion. Keeping this in mind we have conducted a study to examine the serum magnesium, glucose levels and renal parameters in 60 diabetic ESRD patients, before and after hemodialysis. The serum Magnesium level was found to be significantly higher before dialysis in most of the patients which can be attributed to associated cardiovascular and central nervous system complications. However, the level decreased significantly after dialysis. The positive correlation of the results is presented in the Table. After 173 ± 20* 35.6 ± 5.7*** 1.14 ± 0.8*** 3.02 ± 0.5** Hemolysis Statistical comparison was done between before and after values; *p<0.05; **p<0.01;***p<0.001
